Paradigm Biopharmaceuticals | PAR - Market Capitalization

Stock Price
0.24
Daily Change
0.01 4.44%
Monthly
-7.84%
Yearly
-14.55%
Q2 Forecast
0.22

Paradigm Biopharmaceuticals reported AUD79.02M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Avita Medical AUD 105.47M 35.32M Dec/2025
Medical Developments International AUD 62.53M 563.29K Dec/2025
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Pacific Edge NZD 194.21M 87.84M Dec/2025
PYC Therapeutics AUD 965.3M 209.97M Dec/2025
Telix Pharmaceuticals AUD 5.07B 5.81B Dec/2025